The primary objective of this study is to determine if a maternal fetal medicine (MFM) debriefing consult six to eight weeks postpartum reduces self-reported post-traumatic stress, depression, and anxiety symptoms following a delivery complicated by severe maternal morbidity (SMM). Individuals with a delivery complicated an intensive care unit (ICU) admission and/or blood product transfusion \>4 units will be included in this study. Participants will be randomized to an intervention or control group; all participants will complete patient questionnaires that screen for post-traumatic stress disorder, depression, and anxiety. Those in the control group will receive a virtual MFM debriefing consult at six weeks postpartum and those in the intervention group will have the option for a consult at twelve weeks postpartum, after the completion of the questionnaires.
None
Age <18 years
Non-English speakers
Any records flagged "break the glass" or "research opt out"
Parallel
Virtual maternal fetal medicine debriefing consult
BehavioralThe intervention is virtual debriefing consult with a maternal fetal medicine subspecialist. This intervention involves review of the patient's hospital course and delivery experience, and recommendations for future pregnancies if desired.
Depression symptoms
Edinburgh Postnatal Depression Scale (EPDS) score
PTSD symptoms
Impact of Event Scale - Revised (IES-R) score
Anxiety symptoms
Generalized Anxiety Disorder 7-item (GAD-7) score
Click on the lead sponsor to view all of their trials.
Cedars-Sinai Medical Center
Lead sponsor
Cedars Sinai Medical Center, Los Angeles, USA
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
